We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
15 hedge funds and large institutions have $279K invested in Windtree Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
36% more funds holding
Funds holding: 11 → 15 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
46% less capital invested
Capital invested by funds: $521K → $279K (-$242K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$53.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$8.89K |
| 3 |
VF
Virtu Financial
New York
|
-$8.89K |
| 4 |
DM
Deerfield Management
New York
|
-$6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5K |
